Atomoxetine is a non- stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine, a norepinephrine reuptake inhibitor . 更多

Atomoxetine is a non- stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine, a norepinephrine reuptake inhibitor . This chemical is manufactured, marketed and sold under the brand name Strattera by Eli Lilly and Company , the original patent filing company. Generics of atomoxetine are sold into all countries; they are manufactured by Torrent Pharmaceuticals using the label Tomoxetin , Ranbaxy Laboratories (through its Division: Solus) using the label Attentin , Sun Pharmaceuticals (through its Division: Milmet Pharmaceuticals), and Intas Biopharmaceuticals . There is currently no generic manufactured within the United States due to patent license manufacturing restrictions chosen by the owner of the US patent Eli Lilly and Company. less